[1]
|
McCulloh, R. and Patel, K. (2016) Recent Developments in Pediatric Community-Acquired Pneumonia. Current Infectious Disease Reports, 18, 14. https://doi.org/10.1007/s11908-016-0521-1
|
[2]
|
Choi, Y., Chung, E., Lee, E., et al. (2022) Mycoplasma pneumoniae Clinical Characteristics of Macrolide-Refractory Pneumonia in Korean Children: A Multicenter Retrospective Study. Journal of Clinical Medicine, 11, 306.
https://doi.org/10.3390/jcm11020306
|
[3]
|
Yin, Y.D., et al. (2017) Mycoplasma pneumoniae Macrolide-Resistant Prevalence and Clinical Aspects in Adult Patients with Community-Acquired Pneumonia in China: A Prospective Multicenter Surveillance Study. Journal of Thoracic Disease, 9, 3774-3781. https://doi.org/10.21037/jtd.2017.09.75
|
[4]
|
Lee, H., Choi, Y., Sohn, Y., et al. (2021) Mycoplasma pneumoniae Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Pneumonia in Children. Antibiotics (Basel, Switzerland), 10, 192.
https://doi.org/10.3390/antibiotics10020192
|
[5]
|
Guo, D.X., Hu, W.J., Wei, R., et al. (2019) Epidemiology and Mechanism of Drug Resistance of Mycoplasma pneumoniae in Beijing, China: A Multicenter Study. Bosnian Journal of Basic Medical Sciences, 19, 288-296.
https://doi.org/10.17305/bjbms.2019.4053
|
[6]
|
Qu, J., Chen, S., Bao, F., et al. (2019) Molecular Characterization and Analysis of Mycoplasma pneumoniae among Patients of All Ages with Community-Acquired Pneumonia during an Epidemic in China. International Journal of Infectious Diseases, 83, 26-31. https://doi.org/10.1016/j.ijid.2019.03.028
|
[7]
|
Wu, T., Wang, N., Liu, F., et al. (2021) Mycoplasma pneumoniae Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children with Infection. Open Forum Infectious Diseases, 8, ofab416.
https://doi.org/10.1093/ofid/ofab416
|
[8]
|
Kim, J.H., Kim, J.Y., Yoo, C.H., et al. (2017) Macrolide Resistance and Its Impacts on M. pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea. Allergy, Asthma & Immunology Research, 9, 340-346.
https://doi.org/10.4168/aair.2017.9.4.340
|
[9]
|
Oishi, T., Takahashi, K., Wakabayashi, S., et al. (2019) Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods. Antimicrobial Agents and Chemotherapy, 63, 1-6. https://doi.org/10.1128/AAC.02517-18
|
[10]
|
Razin, S., Yogev, D. and Naot, Y. (1998) Molecular Biology and Pathogenicity of Mycoplasmas. Microbiology and Molecular Biology Reviews: MMBR, 62, 1094-1156. https://doi.org/10.1128/MMBR.62.4.1094-1156.1998
|
[11]
|
Waites, K., Xiao, L., Liu, Y., et al. (2017) Mycoplasma pneumoniae from the Respiratory Tract and beyond. Clinical Microbiology Reviews, 30, 747-809. https://doi.org/10.1128/CMR.00114-16
|
[12]
|
李少丽, 孙红妹. 肺炎支原体大环内酯类抗生素全球耐药现状和耐药机制研究进展[J]. 中华微生物学和免疫学杂志, 2018, 38(5): 395-400.
|
[13]
|
Li, S.L., Sun, H.M., Zhu, B.L., et al. (2017) Whole Genome Analysis Reveals New Insights into Macrolide Resistance in Mycoplasma pneumoniae. Biomedical and Environmental Sciences: BES, 30, 343-350.
|
[14]
|
中华医学会儿科学分会临床检验学组. 儿童肺炎支原体呼吸道感染实验室诊断中国专家共识[J]. 中华检验医学杂志, 2019, 42(7): 507-513.
|
[15]
|
Lucier, T.S., et al. (1995) Transition Mutations in the 23S rRNA of Erythromycin-Resistant Isolates of Mycoplasma pneumoniae. Antimicrobial Agents and Chemotherapy, 39, 2770-2773. https://doi.org/10.1128/AAC.39.12.2770
|
[16]
|
Miranda, P.V.D.H., Tatay-Dualde, J., Christian, D.L.F., et al. (2017) Molecular Resistance Mechanisms of Mycoplasma agalactiae to Macrolides and Lincomycin. Veterinary Microbiology, 211, 135-140.
https://doi.org/10.1016/j.vetmic.2017.10.012
|
[17]
|
Cao, B., Qu, J.-X.,Yin, Y.-D., et al. (2017) Overview of Antimicrobial Options for Mycoplasma pneumoniae Pneumonia: Focus on Macrolide Resistance. The Clinical Respiratory Journal, 11, 419-429. https://doi.org/10.1111/crj.12379
|
[18]
|
Lu, C., Yen, T., Chang, L., et al. (2020) Multiple-Locus Variable-Number Tandem-Repeat Analysis (MLVA) of Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae in Children in Taiwan. Journal of the Formosan Medical Association, 119, 1539-1545. https://doi.org/10.1016/j.jfma.2019.12.008
|
[19]
|
Lee, H., Yun, K.W., Lee, H.J., et al. (2018) Antimicrobial Therapy of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children. Expert Review of Anti-Infective Therapy, 16, 23-34.
https://doi.org/10.1080/14787210.2018.1414599
|
[20]
|
Ahn, J., Cho, H., Li, D., et al. (2021) Efficacy of Tetracyclines and Fluoroquinolones for the Treatment of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Children: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 21, Article No. 1003. https://doi.org/10.1186/s12879-021-06508-7
|
[21]
|
Kawai, Y., Miyashita, N., Yamaguchi, T., et al. (2012) Clinical Efficacy of Macrolide Antibiotics against Genetically Determined Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Paediatric Patients. Respirology (Carlton, Vic), 17, 354-362. https://doi.org/10.1111/j.1440-1843.2011.02102.x
|
[22]
|
Ishiguro, N., Koseki, N., Kaiho, M., et al. (2017) Therapeutic Efficacy of Azithromycin, Clarithromycin, Minocycline and Tosufloxacin against Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Pediatric Patients. PLoS ONE, 12, e0173635. https://doi.org/10.1371/journal.pone.0173635
|
[23]
|
Principi, N. and Esposito, S. (2013) Macrolide-Resistant Mycoplasma pneumoniae: Its Role in Respiratory Infection. The Journal of Antimicrobial Chemotherapy, 68, 506-511. https://doi.org/10.1093/jac/dks457
|
[24]
|
Tsai, T., Tsai, C., Kuo, K., et al. (2021) Rational Stepwise Approach for Mycoplasma pneumoniae Pneumonia in Children. Journal of Microbiology, Immunology, and Infection, 54, 557-565. https://doi.org/10.1016/j.jmii.2020.10.002
|
[25]
|
Cardinale, F., Chironna, M., Chinellato, I., et al. (2013) Clinical Relevance of Mycoplasma pneumoniae Macrolide Resistance in Children. Journal of Clinical Microbiology, 51, 723-724. https://doi.org/10.1128/JCM.02840-12
|
[26]
|
Dai, F.F., Liu, F.Q., Chen, X., et al. (2021) The Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children. Journal of Clinical Pharmacy and Therapeutics, 46, 705-710. https://doi.org/10.1111/jcpt.13331
|
[27]
|
Kawai, Y., Miyashita, N., Kubo, M., et al. (2013) Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients. Antimicrobial Agents and Chemotherapy, 57, 2252-2258. https://doi.org/10.1128/AAC.00048-13
|
[28]
|
Jackson, M. and Schutze, G. (2016) The Use of Systemic and Topical Fluoroquinolones. Pediatrics, 138, e20162706.
https://doi.org/10.1542/peds.2016-2706
|
[29]
|
Patel, K. and Goldman, J. (2016) Safety Concerns Surrounding Quinolone Use in Children. Journal of Clinical Pharmacology, 56, 1060-1075. https://doi.org/10.1002/jcph.715
|
[30]
|
Gough, A., Barsoum, N., Mitchell, L., McGuire, E., et al. (1979) Juvenile Canine Drug-Induced Arthropathy: Clinicopathological Studies on Articular Lesions Caused by Oxolinic and Pipemidic Acids. Toxicology and Applied Pharmacology, 51, 177-187. https://doi.org/10.1016/0041-008X(79)90020-6
|
[31]
|
Binz, J., Adler, C. and So, T. (2016) The Risk of Musculoskeletal Adverse Events with Fluoroquinolones in Children: What Is the Verdict Now? Clinical Pediatrics, 55, 107-110. https://doi.org/10.1177/0009922815599959
|
[32]
|
Kim, Y., Park, G., Kim, S., et al. (2021) Fluoroquinolone and No Risk of Achilles-Tendinopathy in Childhood Pneumonia under Eight Years of Age—A Nationwide Retrospective Cohort. Journal of Thoracic Disease, 13, 3399-3408.
https://doi.org/10.21037/jtd-20-2256
|
[33]
|
Bradley, J., Kauffman, R., Balis, D., et al. (2014) Assessment of Musculoskeletal Toxicity 5 Years after Therapy with Levofloxacin. Pediatrics, 134, e146-e153. https://doi.org/10.1542/peds.2013-3636
|
[34]
|
Chopra, I. and Roberts, M. (2001) Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiology and Molecular Biology Reviews: MMBR, 65, 232-260.
https://doi.org/10.1128/MMBR.65.2.232-260.2001
|
[35]
|
Okada, T., Morozumi, M., Tajima, T., et al. (2012) Rapid Effectiveness of Minocycline or Doxycycline against Macrolide-Resistant Mycoplasma pneumoniae Infection in a 2011 Outbreak among Japanese Children. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 55, 1642-1649.
https://doi.org/10.1093/cid/cis784
|
[36]
|
Grossman, E., Walchek, A. and Freedman, H. (1971) Tetracyclines and Permanent Teeth: The Relation between Dose and Tooth Color. Pediatrics, 47, 567-570. https://doi.org/10.1542/peds.47.3.567
|
[37]
|
Todd, S., Dahlgren, F., Traeger, M., et al. (2015) No Visible Dental Staining in Children Treated with Doxycycline for Suspected Rocky Mountain Spotted Fever. The Journal of Pediatrics, 166, 1246-1251.
https://doi.org/10.1016/j.jpeds.2015.02.015
|
[38]
|
Uehara, S., Sunakawa, K., Eguchi, H., et al. (2011) Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with Focus on Pneumonia. Pediatrics International: Official Journal of the Japan Pediatric Society, 53, 264-276. https://doi.org/10.1111/j.1442-200X.2010.03316.x
|
[39]
|
Bébéar, C., Pereyre, S. and Peuchant, O. (2011) Mycoplasma pneumoniae: Susceptibility and Resistance to Antibiotics. Future Microbiology, 6, 423-431. https://doi.org/10.2217/fmb.11.18
|